Ascend Laboratories, LLC is recalling 9,216 bottles of Metoprolol Succinate Extended-Release Tablets (25 mg), a prescription medication used to treat high blood pressure, heart failure, and chest pain. The recall was initiated because the tablets failed dissolution specifications, meaning the medication may not be absorbed by the body at the correct rate. No injuries or adverse events have been reported in connection with this recall.
If the medication does not dissolve properly, the patient may receive too much or too little of the drug at one time, which can lead to poorly controlled blood pressure or other cardiovascular issues.
You have 2 options:
Manufactured by Alkem Laboratories Ltd. and distributed by Ascend Laboratories, LLC.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.